Amgen Inc.
AMGNAmgen Inc. (AMGN) is a Healthcare company that currently yields 2.66% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $257.58 and the overvaluation threshold at $325.16. Amgen Inc. holds a quality score of 67/100 (Good), reflecting 14 consecutive years of dividend growth with a 67% payout ratio. The 5-year dividend CAGR stands at 8.3%.
AMGN Dividend Yield History — Weiss Valuation
Distance to undervalued
Entry price is stretched
Needs 28.1% downside to reach the Weiss buy zone
Undervaluation starts near $257.58, where the annual dividend would imply roughly 3.70% yield. That is 1.04% above today's yield.
Buy-zone price
$257.58
Target yield
3.70%
Research checklist
What to clear before buying the yield
Updated Jun 29, 2026
Dividend durability
14YLong dividend history supports a deeper look.
Earnings payout
67%Earnings coverage leaves room for noise.
Cash payout
73%Free cash flow coverage supports the payment.
Dividend growth
8.3%Recent growth adds income compounding potential.
What changed
What changed since the last update
2026-06-28 → 2026-06-29
No major change in signal, yield, price, quality, or payout since the last update.
Why Now?
Amgen Inc. is trading near its historical overvaluation band.
Current yield 2.7% vs historical max 3.6% (74% of maximum).
14 consecutive years without a dividend cut.
Reasonable payout ratio of 67%.
What matters now
Read the signal before the headline yield
Valuation is the brake here: the yield is compressed versus its own history.
The 67/100 quality score calls for selective follow-up, not autopilot.
Start by checking whether payout coverage and business durability still support the dividend.
AMGN Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$288
Year 10 Income
$842
Yield on Cost
8.92%
Total Income
$5,124
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
Track actual vs. projected
See what AMGN dividends you actually received with Sharesight
Dividend income log · Yield on cost · DRIP cost basis · Tax reports
More research
Full price history & technical analysis
TradingView ↗Fundamentals, valuation & analyst ratings
FinViz ↗Moat rating & analyst fair value
Morningstar ↗Track dividends received & tax reports
Sharesight ↗AMGN Dividend Quality Score
Quality Score
Good
Key Metrics
Invest in AMGN
Buy Amgen Inc. commission-free on eToro
Start investing on eToro →DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.
In-depth analysis
→ AMGN Dividend Analysis Article